“Precision Medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This definition has been made by the Precision Medicine Initiative and is pharmaLevers preferred definition. Precision medicine constitutes a fundamental conceptual change in the way clinical and coverage decisions should be made. Many experts agree that reimbursement is the most important challenge to precision medicine, neither science nor technology.
pharmaLevers is helping clients in the following way:
- Assisting clients to get adequate reimbursement of precision medicine and targeted therapies
- Help medical devices companies to escape the cost plus coverage trap towards VBP
- Help to adapt Market Access Agreements towards an adaptive P&R process
- Economic assessment of treatment algorithms and clinical pathways